REVOLUTIONARY
immune-profiling technology.
Human Data
Feromics maps the gene programs that distinguish high-performing immune cells from the rest. By analyzing thousands of genes across hundreds of human samples, we reveal hidden mechanistic networks where distinct biological processes show correlated activity, working in concert to drive immune cell function. These integrated wiring diagrams expose how cytotoxicity, signaling, and metabolic states converge, not as isolated pathways, but as a single interconnected system that determines whether an immune response succeeds or fails.
After training our Omnix AI framework on hundreds of human samples, we observe a striking bimodal split between high and low effector immune cells. Behind this functional divide sits a precise molecular signature that Omnix learns to recognize from a donor's transcriptional state alone, turning a complex biological readout into a single, actionable score. This is the foundation for identifying responders, optimizing cell therapies, and ultimately engineering immune function at scale.
Human Data
Feromics maps the gene programs that distinguish high-performing immune cells from the rest. By analyzing thousands of genes across hundreds of human samples, we reveal hidden mechanistic networks where distinct biological processes show correlated activity, working in concert to drive immune cell function. These integrated wiring diagrams expose how cytotoxicity, signaling, and metabolic states converge, not as isolated pathways, but as a single interconnected system that determines whether an immune response succeeds or fails.
After training our Omnix AI framework on hundreds of human samples, we observe a striking bimodal split between high and low effector immune cells. Behind this functional divide sits a precise molecular signature that Omnix learns to recognize from a donor's transcriptional state alone, turning a complex biological readout into a single, actionable score. This is the foundation for identifying responders, optimizing cell therapies, and ultimately engineering immune function at scale.
Human Data
Feromics maps the gene programs that distinguish high-performing immune cells from the rest. By analyzing thousands of genes across hundreds of human samples, we reveal hidden mechanistic networks where distinct biological processes show correlated activity, working in concert to drive immune cell function. These integrated wiring diagrams expose how cytotoxicity, signaling, and metabolic states converge, not as isolated pathways, but as a single interconnected system that determines whether an immune response succeeds or fails.
After training our Omnix AI framework on hundreds of human samples, we observe a striking bimodal split between high and low effector immune cells. Behind this functional divide sits a precise molecular signature that Omnix learns to recognize from a donor's transcriptional state alone, turning a complex biological readout into a single, actionable score. This is the foundation for identifying responders, optimizing cell therapies, and ultimately engineering immune function at scale.
OmniX: AI Built on Functional Biology
OmniX is trained on our proprietary functionally labeled immunomics datasets, among the world’s largest of their kind. Rather than measuring immune-cell activation alone, the platform learns which biological programs are truly associated with therapeutic function, persistence, resistance, and clinical response.
METRICS
Data size: >10 PB
# of cells: >250 Million
>1000 human samples
OmniX: AI Built on Functional Biology
OmniX is trained on our proprietary functionally labeled immunomics datasets, among the world’s largest of their kind. Rather than measuring immune-cell activation alone, the platform learns which biological programs are truly associated with therapeutic function, persistence, resistance, and clinical response.
Metrics:
Data size: >10 PB
# of cells: >250 Million
>1000 human samples
METRICS
Data size: >10 PB
# of cells: >250 Million
>1000 human samples
Data size: >10 PB
>1000 human samples
# of cells: >250 Million
THERAPEUTIC PIPELINE
Feromics is actively applying its platform toward the development of new therapies.
Feromics is actively applying its platform toward the development of new therapies.
PROGRAM
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
Diffuse large B-cell lymphoma (DLBCL)
F01-50 ID-CAR-T
Undisclosed indication
F03-50 ID-CAR-T
CLINICAL APPLICATIONS OF OMNIX
AML — Donor Selection for DLI and HSCT
OmniX AI platform is designed to improve donor selection for AML patients undergoing hematopoietic stem cell transplantation (HSCT) and donor lymphocyte infusion (DLI).
Rather than relying solely on HLA matching, OmniX functionally profiles donor immune cell is to identify the molecular programs associated with durable anti-leukemic activity, persistence, and reduced exhaustion.
By linking real tumor-killing behavior with AI-driven transcriptomic analysis, Feromics aims enable more predictive donor selection strategies and improve long-term immune control in AML.